Presymptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data

Author:

Casey-Bryars MiriamORCID,Griffin JohnORCID,McAloon ConorORCID,Byrne AndrewORCID,Madden Jamie,Mc Evoy DavidORCID,Collins Áine,Hunt Kevin,Barber Ann,Butler Francis,Lane Elizabeth AnnORCID,O'Brien Kirsty,Wall Patrick,Walsh Kieran,More Simon JohnORCID

Abstract

ObjectiveTo estimate the proportion of presymptomatic transmission of SARS-CoV-2 infection that can occur, and the timing of transmission relative to symptom onset.Setting/designSecondary analysis of international published data.Data sourcesMeta-analysis of COVID-19 incubation period and a rapid review of serial interval and generation time, which are published separately.ParticipantsData from China, the Islamic Republic of Iran, Italy, Republic of Korea, Singapore and Vietnam from December 2019 to May 2020.MethodsSimulations were generated of incubation period and of serial interval or generation time. From these, transmission times relative to symptom onset, and the proportion of presymptomatic transmission, were estimated.Outcome measuresTransmission time of SARS-CoV-2 relative to symptom onset and proportion of presymptomatic transmission.ResultsBased on 18 serial interval/generation time estimates from 15 papers, mean transmission time relative to symptom onset ranged from −2.6 (95% CI −3.0 to –2.1) days before infector symptom onset to 1.4 (95% CI 1.0 to 1.8) days after symptom onset. The proportion of presymptomatic transmission ranged from 45.9% (95% CI 42.9% to 49.0%) to 69.1% (95% CI 66.2% to 71.9%).ConclusionsThere is substantial potential for presymptomatic transmission of SARS-CoV-2 across a range of different contexts. This highlights the need for rapid case detection, contact tracing and quarantine. The transmission patterns that we report reflect the combination of biological infectiousness and transmission opportunities which vary according to context.

Publisher

BMJ

Subject

General Medicine

Reference64 articles.

1. WHO . COVID-19 situation reports, 2020. Available: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports [Accessed 19 Apr 2021].

2. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

3. Roberts L . Polio, measles, other diseases set to surge as COVID-19 forces suspension of vaccination campaigns | Science | AAAS. Sci. Mag. Newsl, 2020. Available: https://www.sciencemag.org/news/2020/04/polio-measles-other-diseases-set-surge-covid-19-forces-suspension-vaccination-campaigns [Accessed 4 May 2020].

4. Effect of the COVID-19 pandemic on cancer treatment and research;Saini;Lancet Haematol,2020

5. COVID-19, unemployment, and suicide;Kawohl;Lancet Psychiatry,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3